Synthesis and evaluation of fluorinated tetrahydrocarbazoles as probes in NMR based binding assay of the E. coli β sliding clamp

Cecilie Elisabeth Olsen, Signe Simonsen, Srinivas Reddy Merugu, Vaclav Eigner, Finn L. Aachmann, Birthe B. Kragelund, Eirik Sundby, Bård Helge Hoff*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

Bacterial β sliding clamp (β-clamp) is an emerging drug target currently lacking small-molecule inhibitors with good in vivo activity. Thus, there is a need for fast and simple screening methods for identifying inhibitor candidates. Here we demonstrate the use of nuclear magnetic resonance spectroscopy (NMR) for evaluating compound binding to the E. coli β-clamp. To identify suitable molecular probes, a series of tetrahydrocarbazoles were synthesized, some of which contain fluorine. Key challenges in the synthesis were formation of regioisomers during the Fischer indole reaction and reducing racemization at the stereogenic center. The tetrahydrocarbazoles were assayed against the E. coli β-clamp by saturation-transfer difference (STD) NMR, waterLOGSY and T1ρ. Analysis by isothermal titration calorimetry gave KD-values of 1.7–14 μM for three fluorinated probe candidates, and NMR chemical shift perturbation experiments confirmed these molecules to directly interact with the β-clamp binding pocket. Binding of the fluorinated molecules to β-clamp was easily observed with 19F-observed T2-based binding experiments, and proof of concept for a fluorine-based binding assay for E. coli β-clamp binders is provided.
OriginalsprogEngelsk
Artikelnummer118139
TidsskriftBioorganic and Medicinal Chemistry
Vol/bind122
Antal sider14
ISSN0968-0896
DOI
StatusUdgivet - 2025

Bibliografisk note

Funding Information:
The work was supported by Trond Mohn Research Foundation, Bergen, Norway , and the Novo Nordisk Foundation (grant no.: NNF18OC0033926 ; to B.B.K.). NMR spectra were recorded in part at the cOpenNMR an infrastructure supported by the Novo Nordisk Foundation (grant no.: NNF18OC0032996 ) and in part at the Norwegian NMR Platform (project number 226244/F50 ). Assistance from the Mass Spectrometry Lab at the NV Faculty at NTNU and Roger Aarvik for technical support are also acknowledged.

Publisher Copyright:
© 2025 The Author(s)

Citationsformater